Jiangsu Nhwa Pharmaceutical: Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth

About this update from Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A

Revenue rose 8.93% and net profit grew 11.38% year-over-year, driven by strong CNS drug sales and increased R&D investment. The company maintained high gross margins, expanded digital healthcare, and implemented a new stock incentive plan.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A